Christopher Thompson
Advertisement
Christopher Thompson obtained his PhD in Physical Chemistry at the University of Massachusetts Amherst. He spent 17 years at Bruker Daltonics in various scientific roles, ultimately as Global Business Development Manager for the FT-ICR business unit. Chris moved to BrightSpec in late 2020 to lead the commercialization of MRR, and is currently the Vice President of Commercial Development.
Articles by Christopher Thompson
Advertisement
Latest Updated Articles
MRR: A New Tool in Applied Analysis for the Pharmaceutical IndustryPublished: September 10th 2024 | Updated:
Advertisement
Advertisement
Trending on Spectroscopy Online
1
New Review Highlights Spectroscopy Breakthroughs in Monitoring Pharmaceutical Fermentation
2
The Advantages of LIBS for Forensic Analysis of Bones and Fossils
3
Best of the Week: Analyzing Bone Chemistry, Pharmaceutical Fermentation, Drug Intelligence
4
Spectroscopy and Chemometrics Pave the Way for Safer, Higher-Quality Food
5
